ES8601705A1 - Un procedimiento para la produccion de un factor endogeno humano regulador del cancer - Google Patents

Un procedimiento para la produccion de un factor endogeno humano regulador del cancer

Info

Publication number
ES8601705A1
ES8601705A1 ES528971A ES528971A ES8601705A1 ES 8601705 A1 ES8601705 A1 ES 8601705A1 ES 528971 A ES528971 A ES 528971A ES 528971 A ES528971 A ES 528971A ES 8601705 A1 ES8601705 A1 ES 8601705A1
Authority
ES
Spain
Prior art keywords
human
preparing
regulatory factor
pharmaceutical composition
cell lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES528971A
Other languages
English (en)
Other versions
ES528971A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES528971A0 publication Critical patent/ES528971A0/es
Publication of ES8601705A1 publication Critical patent/ES8601705A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UN FACTOR ENDOGENO HUMANO REGULADOR DEL CANCER. COMPRENDE EL CRECIMIENTO DE CELULAS NORMALES O LEUCEMICAS MONOCITICAS HUMANAS, EN UN MEDIO DE CULTIVO DE TEJIDOS QUE CONTIENE SUERO FETAL DE TERNERA, EN PRESENCIA DE UN PRIMER ESTIMULANTE QUE ES UNA SUSTANCIA ACTIVANTE DE MACROFAGOS COMO 13-ACETATO DE 12-O-TETRADECANOILFORBOL; ADICIONAR DESPUES UN SEGUNDO ESTIMULANTE COMO UNA ENDOTOXINA PRODUCIDA POR BACTERIAS GRAM-NEGATIVAS O GRAM-POSITIVAS AL MEDIO DE CULTIVO PARA PRODUCIR EL FACTOR ENDOGENO HUMANO REGULADOR DEL CANCER Y RECUPERAR DICHO FACTOR REGULADOR DEL MEDIO DE CULTIVO.
ES528971A 1983-07-14 1984-01-18 Un procedimiento para la produccion de un factor endogeno humano regulador del cancer Expired ES8601705A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58128893A JPS6019720A (ja) 1983-07-14 1983-07-14 ヒト内来性癌制御因子およびその製造法

Publications (2)

Publication Number Publication Date
ES528971A0 ES528971A0 (es) 1985-07-01
ES8601705A1 true ES8601705A1 (es) 1985-07-01

Family

ID=14995948

Family Applications (1)

Application Number Title Priority Date Filing Date
ES528971A Expired ES8601705A1 (es) 1983-07-14 1984-01-18 Un procedimiento para la produccion de un factor endogeno humano regulador del cancer

Country Status (7)

Country Link
EP (1) EP0134923A3 (es)
JP (1) JPS6019720A (es)
CA (1) CA1224172A (es)
DK (1) DK607683D0 (es)
ES (1) ES8601705A1 (es)
GR (1) GR81438B (es)
PH (1) PH22226A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5198428A (en) * 1991-04-05 1993-03-30 Board Of Regents, The Univ. Of Texas System Macrophage cytotoxin compositions and methods of preparation
DE4124758A1 (de) * 1991-07-25 1993-01-28 Max Planck Gesellschaft Antitumorwirksame substanz aus humanen makrophagen
CA2649914C (en) * 2006-04-28 2014-06-17 Telefonaktiebolaget L M Ericsson (Publ) Method and device for coupling cancellation of closely spaced antennas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles

Also Published As

Publication number Publication date
GR81438B (es) 1984-12-11
EP0134923A2 (en) 1985-03-27
ES528971A0 (es) 1985-07-01
PH22226A (en) 1988-07-01
CA1224172A (en) 1987-07-14
EP0134923A3 (en) 1986-12-03
DK607683D0 (da) 1983-12-30
JPS6019720A (ja) 1985-01-31

Similar Documents

Publication Publication Date Title
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
AU594488B2 (en) Agents for the treatment of arthroses
PH21834A (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
MY102586A (en) Medicaments for paf acether induced maladies
NO159104C (no) Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5.
AU559983B2 (en) Platinum complexes, treatment of cancer
YU106789A (en) Process for obtaining 1,3-diole from epoxyde
AU4484989A (en) Water soluble 1,2-diaminocyclohexane platinum (iv) complexes as antitumor agents
AU6978681A (en) Cis-isocitrato (1,2-diaminocyclohexane) platinum (11)
GB2043642B (en) Ethylenediamine platinum (ii)and 1,2-diaminocyclohexaneplatinum (ii) pyrophosphate complexes
AU562807B2 (en) Tetrapeptides
JO1406B1 (en) Chemical compounds
ES8601705A1 (es) Un procedimiento para la produccion de un factor endogeno humano regulador del cancer
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes
IL73825A0 (en) Compositions containing an n,n'-alkylenediamide or and amidoalkylimidazole derivative and process for preparing the same
IL75018A (en) Chartreusin derivatives,salts thereof,antitumor compositions containing the same,and processes for producing the same
DE3767728D1 (en) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
AU639804B2 (en) Novel platinum (ii) complex and drug for treating malignant tumor
HUT42075A (en) Process for producing 2,2-comma above-bi/1h-imidazol/ derivatives
EP0130882A3 (en) Bicyclo(3.2.1)octane carboxylic-acid derivatives, processes for their preparation and their therapeutical use
IE821021L (en) Bipolar electrolysis apparatus, paerticularly for the¹electrolysis of saline solutions
RO87212B1 (ro) Derivati de p-fluorbenzamida
HRP930888B1 (en) Process for the preparation of 7,16-dioxa-2-aza-10-0-cladynozyl-12-0-desozaminyl-4,5-dihydroxy-5-ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1) hexadeca-1(2)-en-8-ones
ZA847466B (en) Azole derivatives,process for their production compositions containing them and their use
CS857486A1 (en) Etylen vinylacetatov kopolymer obsahujuci 7,15 diazadispiro ( 5,1,5,3 ) hexadecyl skupiny